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Policy Implications
Our results support current hospice payment reform and could be informative to future reform efforts. In 
2016, the Centers for Medicare & Medicaid Services (CMS) began paying hospices a lower rate after the 
first 60 days in hospice, consistent with our findings that very long hospice stays do not have reduced total 
spending. However, most hospice users enrolled less than a month before death, and it is likely that many 
would have been suitable candidates for either palliative care or hospice care earlier. Thus, future policies 
that encourage earlier discussions and timely initiation of hospice care have the potential to increase the 
magnitude of the successes observed in our study while maintaining program goals.
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Research Problem
Does hospital use and Medicare spending prior to a patient’s death differ by use of hospice at death, 
length of hospice care, or nursing home residency?
The Medicare hospice benefit was passed into law in 1982, with the goal of improving the quality of 
end-of-life care by providing palliative and support services for terminally ill patients during the final 
6 months of life. Initially, hospices primarily served Medicare beneficiaries with cancer, but by 2008, 
noncancer diagnoses accounted for 69% of all hospice users. In recent years, more older adults started 
using the benefit, increasing from 23% of Medicare decedents in 2000 to 44% in 2010. During the same 
time period, the proportion of decedents with long hospice stays has grown; during the same period, the 
mean hospice stay increased from 54 to 86 days, although the median hospice stay remained relatively 
constant at approximately 18 days.
Key Findings
(a) Overall, the Medicare hospice 
benefit is successful in avoid-
ing hospital care at the end of 
life: hospice use over 2 weeks 
was associated with decreased 
hospital days (1–5  days, with 
greater decreases for longer 
hospice use) for all beneficiaries.
(b) For most beneficiaries not in 
nursing homes, total Medicare 
spending was lower with hos-
pice use, with the greatest 
reductions ($900–$5,000) with 
31–90 days in hospice. However, 
beneficiaries with Alzheimer’s 
disease had increased spend-
ing for any length of hospice use 
(Figure 2).
(c) For beneficiaries in nursing 
homes, expenditures increased 
with hospice use for Alzheimer’s 
disease, stroke, and heart fail-
ure; only beneficiaries with lung 
cancer had decreased spending 
($3,500). (Figure 2).
Data and Methods
We compared inpatient hospital days and Medicare spending during the last 6 months of life using hospice 
versus propensity matched nonhospice beneficiaries, who died in 2010, were enrolled in fee-for-service 
Medicare throughout the last 2 years of life and were in at least one of five disease groups (Alzheimer’s 
disease or related dementias [ADRD], heart failure, stroke, lung cancer, or colorectal cancer). Comparisons 
were based on length of hospice use and whether the decedent was in a nursing home during the 7th 
month prior to death. We regressed a categorical measure of hospice days on outcomes, controlling for 
observed patient characteristics.
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Figure 2. Estimated difference in total Medicare spending during the last 
6 months of life by NH use in the 7th month prior to death for hospice 
decedents as compared with nonhospice decedents (adjusted regression 
coefficients for hospice use). *Not statistically significant as compared 
with nonhospice decedents. ADRD - Alzheimer’s disease and related 
dementia.
Figure 1. Estimated difference in hospital use during the last 6 months 
of life by nursing home use in the 7th month prior to death for hospice 
decedents as compared with nonhospice decedents (adjusted regres-
sion coefficients for hospice use). All estimates are statistically sig-
nificant as compared with nonhospice decedents. ADRD = Alzheimer’s 
disease and related dementia.
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